Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q2 | Jul 30, 2024 | Rozendal Partners | - | 5.5% | 836807 CH, B4B GR, BAYN GR, CGR SJ, HARMCMI LN, HCI, KSPI, META, MTN SJ, NPK SJ, PPC SJ | - | View | ||
| 2025 Q2 | Jul 22, 2025 | Harris Associates International Equity Strategy | 12.8% | 21.7% | 105560 KS, 6273 JP, ASML, ASRNL NA, BABA, BAYN GR, CON GR, MC FP, WLN FP | Balance Sheets, currency effects, International Value, Sentiment, Valuation Discount | The letter highlights international equities as a fertile hunting ground for value opportunities due to persistent investor pessimism and currency-adjusted discounts. Management focuses on globally competitive companies trading below intrinsic value because of temporary macro or sentiment-driven headwinds. A long-term horizon and balance-sheet strength underpin the return outlook. | 6273 JP ASML MC FP BABA BAYN GR CON GR 105560 KS |
View |
| 2024 Q1 | Apr 15, 2024 | Oakmark International Fund | 8.8% | 0.0% | BAYN GR, BXB AU, DTG GR, SKG LN, SN/ LN | - | View | ||
| 2024 Q1 | Apr 15, 2024 | Harris Associates International Equity Strategy | 0.2% | 0.2% | BAYN GR, BXB AU, CON GR, DTG GR, IES GR, MBG GR, PRU LN, SKG LN, SN/ LN | - | View | ||
| 2024 Q4 | Dec 31, 2024 | Oakmark International Fund | -8.5% | -4.6% | AIR FP, BAYN GR, KB | - | View | ||
| 2024 Q4 | Dec 31, 2024 | Oakmark Global Select Fund | -5.0% | 4.7% | BAYN GR, COF, DEO, ELV, SCHW | - | View | ||
| 2024 Q4 | Dec 31, 2024 | Oakmark Global Fund | -5.8% | 2.5% | BAYN GR, BDX, COF, DSV CN, ELV, MTN | - | View | ||
| 2023 Q4 | Jan 29, 2024 | Rozendal Partners | - | 21.6% | B4B GR, BAYN GR, BOWLF, BUR, CCO CN, CCOLA TI, CMCCOEQ SJ, COH SJ, MTN SJ, PPC SJ, TBS SJ | - | View | ||
| 2023 Q4 | Aug 1, 2024 | Oakmark Global Fund | 7.5% | 0.0% | A, BAYN GR, COF, KR, ORCL, ROG SW | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2026 | Fund Letters | Ravenel B. Curry III | Bayer AG | Health Care | Pharmaceuticals | Bull | Xetra | agriculture, Free Cash Flow, litigation, Seeds, turnaround | View Pitch |
| Jan 30, 2026 | Fund Letters | Wilhelm Hertzog | Bayer AG | Health Care | Pharmaceuticals | Bull | Xetra | litigation, pharmaceuticals, pipeline, rerating, turnaround | View Pitch |
| Jan 28, 2026 | Fund Letters | David Herro | Bayer AG | Health Care | Pharmaceuticals | Bull | Xetra | litigation, pharma, pipeline, Regulation, turnaround | View Pitch |
| Jan 27, 2026 | Fund Letters | William C. Nygren | Bayer AG | Health Care | Pharmaceuticals | Bull | Xetra | litigation, pharmaceuticals, pipeline, turnaround, valuation | View Pitch |
| Jan 8, 2026 | Fund Letters | David Herro | Bayer AG | Health Care | Pharmaceuticals | Bull | Xetra | conglomerate, Cropscience, litigation, pharma, restructuring, valuation | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||